Compare StocksAVGO vs CVS

Broadcom Inc. (AVGO) vs CVS Health Corporation (CVS): Which Is the Better Buy in 2026?

As of 2026-06-19, AVGO is overvalued at $411, with a DCF intrinsic value of $258 and a margin of safety of -59%. CVS is overvalued at $98, with an intrinsic value of $28 and a margin of safety of -253%. Of the two, AVGO has the wider margin of safety.

AVGO
Broadcom Inc.
$411.35
VS
CVS
CVS Health Corporation
$98.32

Rewards

AVGO
  • Gross margin of 76.3% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • Free cash flow has grown at a 18.2% CAGR over the past 4 years, demonstrating strong earnings power growth.
  • Each dollar of retained earnings has created $11.66 of earning power — management is an exceptional capital allocator.
CVS
  • Management has timed buybacks well — 2 out of 3 years showed value-accretive repurchases.
  • PEG ratio of 0.28 suggests the stock is undervalued relative to its growth rate — paying less than 1x for each unit of earnings growth.

Risks

AVGO
  • ROIC has declined by 6.5 percentage points over the past 4 years, which may signal competitive erosion.
  • Share count has increased by 13% over the past 4 years, diluting existing shareholders.
  • FCF yield of 1.4% is below 3%, meaning the market is pricing in substantial future growth to justify the current price.
CVS
  • Gross margin of 13.4% is low, suggesting a competitive or commodity-like market with limited pricing power.
  • FCF yield of 6.2% suggests reasonable valuation assuming continued moderate growth.
  • Trailing P/E of 43.1x is 58% above the historical average of 27.4x — the stock trades at a premium to its own history.

Key Valuation Metrics

Learn more →
AVGO
CVS
Valuation
$27.21B
Free Cash Flow
$7.81B
1.39%
FCF Yield
6.22%
68.22
Trailing P/E
43.12
21.26
Forward P/E
11.73
Quality & Moat
19.14%
ROIC
8.47%
37.28%
ROE
3.75%
76.28%
Gross Margin
13.39%
0.68
PEG Ratio
0.28
Balance Sheet Safety
0.52
Net Debt / Equity
0.86
N/A
Interest Coverage
N/A
1.08
Net Debt / EBITDA
4.32
0.69%
Dividend Yield
2.64%
AVGO: 6Ties: 1CVS: 5
AVGOCVS

Historical Fundamentals

Learn more →
AVGO

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

CVS

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
AVGO
$97.03
created per $1 retained over 3 years
Exceptional Value Creator
Σ Retained
$14.50B
Δ Market Cap
+$1.41T
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
CVS
$-4.20
created per $1 retained over 3 years
Market Cap Declined
Σ Retained
$4.82B
Δ Market Cap
$-20.28B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
AVGO
16.0% Margin of Safety
Price is 16.0% below estimated fair value
Current Price: $411.35
Fair Value: $489.83
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
CVS
253.5% Overvalued
Price is 253.5% above estimated fair value
Current Price: $98.32
Fair Value: $27.81
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
AVGO

What growth rate is the market pricing in at $411?

+23.6%
Market-Implied Owner Earnings Growth
Standard FCF implies +25.6%

The market implies +23.6% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +25.6%, reflecting heavy growth investment.

CVS

What growth rate is the market pricing in at $98?

+21.3%
Market-Implied Owner Earnings Growth
Standard FCF implies +10.5%

The market implies +21.3% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +10.5%, reflecting heavy growth investment.

Economic Moat Score

Learn more →
AVGO
61/100
Narrow Moat
70+ Wide · 40-69 Narrow · <40 None

Narrow moat with reinvestment efficiency as the key competitive advantage. Improving revenue predictability would strengthen the moat.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
CVS
49/100
Narrow Moat
70+ Wide · 40-69 Narrow · <40 None

Narrow moat with revenue predictability as the key competitive advantage. Improving roic consistency would strengthen the moat.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.

Forensic Accounting

Learn more →
AVGO
-2.09
Possible Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
CVS
-2.54
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
AVGO
Insiders 1.9%Institutions 79.9%Retail & Other 18.1%
No. of Institutional Holders6,094
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
CVS
Insiders 0.1%Institutions 90.0%Retail & Other 10.0%
No. of Institutional Holders2,455
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
AVGO
0
Buys (3M)
2
Buys (12M)
Total value (12M): $1.55M
YOU HARRY L
Director
$325,129
@ $325.13 · 2025-12-18
YOU HARRY L
Director
$1.23M
@ $345.88 · 2025-09-10
Open market purchases · includes direct & indirect ownership · excludes option exercises
CVS
0
Buys (3M)
0
Buys (12M)
SANSONE GUY P
Director
$100,009
@ $63.70 · 2025-06-05
MAHONEY MICHAEL F
Director
$2.00M
@ $66.70 · 2025-02-18
NELSON STEVEN H
Officer
$1,289
@ $53.71 · 2025-01-23
CAPOZZI HEIDI B
Officer
$4,589
@ $57.36 · 2024-10-23
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
AVGO
4
Sells (3M)
29
Sells (12M)
Total value (12M): $241.47M
VELAGA S. RAM
Officer
$2.96M
@ $370.52 · 2026-04-10
VELAGA S. RAM
Officer
$10.64M
@ $352.08 · 2026-04-09
DELLY GAYLA J
Director
$358,310
@ $358.31 · 2026-04-09
PAGE JUSTINE F.
Director
$712,354
@ $353.00 · 2026-04-08
SPEARS KIRSTEN MARGRETA
Chief Financial Officer
$19.45M
@ $323.38 · 2026-03-17
VELAGA S. RAM
Officer
$20.82M
@ $323.38 · 2026-03-17
BRAZEAL MARK DAVID
Officer
$27.06M
@ $323.39 · 2026-03-17
KAWWAS CHARLIE B
Officer
$20.97M
@ $323.39 · 2026-03-17
BRAZEAL MARK DAVID
Officer
$10.41M
@ $347.12 · 2026-01-06
TAN HOCK E
Chief Executive Officer
$24.31M
@ $347.30 · 2026-01-06
SPEARS KIRSTEN MARGRETA
Chief Financial Officer
$10.43M
@ $347.82 · 2025-12-31
BRAZEAL MARK DAVID
Officer
$9.13M
@ $352.07 · 2025-12-26
SPEARS KIRSTEN MARGRETA
Chief Financial Officer
$2.03M
@ $332.91 · 2025-12-17
BRAZEAL MARK DAVID
Officer
$12.54M
@ $327.65 · 2025-12-17
KAWWAS CHARLIE B
Officer
$1.05M
@ $332.95 · 2025-12-17
BRAZEAL MARK DAVID
Officer
$8.36M
@ $340.91 · 2025-12-16
PAGE JUSTINE F.
Director
$289,512
@ $361.89 · 2025-12-15
PAGE JUSTINE F.
Director
$264,912
@ $331.14 · 2025-11-14
PAGE JUSTINE F.
Director
$280,120
@ $350.15 · 2025-10-14
BRAZEAL MARK DAVID
Officer
$9.59M
@ $352.61 · 2025-09-17
KAWWAS CHARLIE B
Officer
$2.26M
@ $352.74 · 2025-09-17
PAGE JUSTINE F.
Director
$288,000
@ $360.00 · 2025-09-15
PAGE JUSTINE F.
Director
$245,968
@ $307.46 · 2025-08-14
PAGE JUSTINE F.
Director
$219,440
@ $274.30 · 2025-07-14
TAN HOCK E
Chief Executive Officer
$10.73M
@ $268.29 · 2025-06-26
DELLY GAYLA J
Director
$795,390
@ $265.13 · 2025-06-26
SPEARS KIRSTEN MARGRETA
Chief Financial Officer
$9.50M
@ $261.27 · 2025-06-24
BRAZEAL MARK DAVID
Officer
$13.11M
@ $262.10 · 2025-06-24
BRAZEAL MARK DAVID
Officer
$12.66M
@ $253.28 · 2025-06-23
SPEARS KIRSTEN MARGRETA
Chief Financial Officer
$14.18M
@ $251.75 · 2025-06-18
PAGE JUSTINE F.
Director
$200,280
@ $250.35 · 2025-06-16
PAGE JUSTINE F.
Director
$184,152
@ $230.19 · 2025-05-14
PAGE JUSTINE F.
Director
$148,000
@ $185.00 · 2025-04-14
BRAZEAL MARK DAVID
Officer
$5.84M
@ $194.65 · 2025-03-24
LOW CHECK KIAN
Director
$11.30M
@ $235.35 · 2025-01-06
BRAZEAL MARK DAVID
Officer
$4.82M
@ $238.79 · 2024-12-24
TAN HOCK E
Chief Executive Officer
$10.80M
@ $239.96 · 2024-12-24
BRYANT DIANE M
Director
$3.40M
@ $226.68 · 2024-12-23
SPEARS KIRSTEN MARGRETA
Chief Financial Officer
$2.89M
@ $229.62 · 2024-12-20
YOU HARRY L
Director
$1.57M
@ $240.00 · 2024-12-17
BRAZEAL MARK DAVID
Officer
$3.43M
@ $181.45 · 2024-10-11
BRAZEAL MARK DAVID
Officer
$3.46M
@ $182.88 · 2024-10-09
BRAZEAL MARK DAVID
Officer
$3.59M
@ $177.10 · 2024-10-07
DELLY GAYLA J
Director
$130,898
@ $174.53 · 2024-09-25
PAGE JUSTINE F.
Director
$444,566
@ $1750.26 · 2024-06-20
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
CVS
1
Sells (3M)
1
Sells (12M)
Total value (12M): $6.23M
MANDADI TILAK
Officer
$6.23M
@ $89.58 · 2026-05-08
CLARK JAMES DAVID
Officer
$498,488
@ $66.35 · 2025-03-05
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
AVGO
FearGreed
😐Neutral(49/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
CVS
FearGreed
😏Greed(69/100)

"Market is optimistic — be cautious and ensure you have a margin of safety"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
AVGO
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (49)
CVS
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Greed (69)
View AVGO Full AnalysisView CVS Full Analysis

Frequently Asked Questions: AVGO vs CVS

Is Broadcom Inc. or CVS Health Corporation more undervalued in 2026?

Based on our discounted cash flow model, AVGO trades at a -59.4% margin of safety (intrinsic value $258 vs. price $411), compared to CVS's -253.5% margin of safety (intrinsic $28 vs. $98).

Which stock has a wider economic moat, Broadcom Inc. or CVS Health Corporation?

AVGO scores 61/100 (Narrow moat), while CVS scores 49/100 (Narrow moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

Is CVS Health Corporation in financial distress?

CVS's Altman Z-Score of 2.3 places it in the Grey zone, signaling elevated bankruptcy risk. AVGO scores 12.0 (Safe zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

Which company has better free cash flow, Broadcom Inc. or CVS Health Corporation?

CVS Health Corporation (CVS) generates a 6.2% free cash flow yield, compared to Broadcom Inc.'s 1.4%. A higher FCF yield means the business converts more of its market value into cash that can be returned to shareholders or reinvested.

Which stock has higher return on invested capital, Broadcom Inc. or CVS Health Corporation?

AVGO earns 19.1% ROIC versus CVS's 8.5%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

Which dividend is safer, Broadcom Inc.'s or CVS Health Corporation's?

AVGO's dividend earns a safety score of 94/100 (Very Safe), compared to CVS's 45/100 (Borderline). AVGO has raised its dividend for 3 consecutive years.